Posted on February 2nd, 2010 by Health News
Fat tissue in women with Polycystic Ovary Syndrome produces an inadequate amount of the hormone that regulates how fats and glucose are processed, promoting increased insulin resistance and inflammation, glucose intolerance, and greater risk of diabetes and heart disease, according to a study conducted at the Center for Androgen-Related Research and Discovery at [...]
No Comments »
Filed under: Women's Health
Posted on February 2nd, 2010 by Health News
“The U.S. government said on Sunday it would resume military evacuation flights” within 12 hours for critically ill and injured Haitians who were harmed in the Jan. 12 earthquake, Reuters reports (Rosenberg/Brown, 1/31)…
No Comments »
Filed under: Women's Health
Posted on February 2nd, 2010 by Health News
A new study weighs in on the controversy over sex education, finding that an abstinence-only intervention for pre-teens was more successful in delaying the onset of sexual activity than a health-promotion control intervention. After two years, one-third of the abstinence-only group reported having sex, compared to one-half of the control group…
No Comments »
Filed under: Women's Health
Posted on February 2nd, 2010 by Health News
A recent study by the Guttmacher Institute examining teenage pregnancy, birth and abortion rates “suggests the wisdom” of President Obama’s decision to “redirect sex-education financing from an abstinence-only approach to broader, more-effective programs that provide information to young people about contraceptives, pregnancy and sexually transmitted [infections],” a New York T…
No Comments »
Filed under: Women's Health
Posted on February 2nd, 2010 by Health News
LEO Pharma today announced that in a Phase III study, PEP005 (ingenol mebutate) Gel, the company’s lead candidate for the topical treatment of actinic (solar) keratosis (AK) or pre-cancerous lesions, met its primary clinical endpoint of complete clearance of AK lesions in non-head locations.
No Comments »
Filed under: Pharmacy News
Posted on February 2nd, 2010 by Health News
Pervasis Therapeutics, Inc. today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the design of a pivotal Phase 3 clinical trial for Vascugel®, an investigational new drug for the prevention of hemodialysis access graft failure.
No Comments »
Filed under: Pharmacy News
Posted on February 2nd, 2010 by Health News
Romark Laboratories announced that it has initiated enrollment of patients in a clinical trial of Alinia® (nitazoxanide) for treating acute uncomplicated influenza including illness caused by the currently circulating H1N1 strain.
No Comments »
Filed under: Pharmacy News
Posted on February 2nd, 2010 by Health News
Synosia Therapeutics today announced interim positive data from a Phase IIa clinical study of an adenosine 2a (A2a) receptor antagonist (SYN115) in Parkinson’s disease.
No Comments »
Filed under: Pharmacy News
Posted on February 2nd, 2010 by Health News
Diminishing market access has become one of the central challenges for the pharmaceutical industry. Whereas regulatory agency approval used to be the final hurdle in drug development, now pharmaceutical companies must negotiate an obstacle course of reimbursement dossiers, cost-effectiveness studies, decentralized health authorities, and post-launch observational research…
No Comments »
Filed under: Pharmacy News
Posted on February 2nd, 2010 by Health News
Understanding & implementing best practice approaches to value-based sales in the competitive cancer marketplace Conference dates: 15th-16th March, 2010 Venue: Brussels, Belgium This will be the only event looking at “best practice” approaches to selling and marketing high-value cancer drugs, and working in partnership with generalists and specialists such as oncologists, …
No Comments »
Filed under: Pharmacy News
